← Open Payments lookup

AMY ROMICK: Open Payments

NPI 1447771290 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,707 in 134 payments from 13 companies in 2025. Trend: 2023 $166 · 2024 $1,621 · 2025 $2,707

Food & beverage: $2,707
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)22$697
Otsuka America Pharmaceutical, Inc.42$668
Alkermes, Inc.14$266
Neurocrine BioSciences, Inc.13$253
Teva Pharmaceuticals USA, Inc.9$157
Lundbeck LLC9$140
Vanda Pharmaceuticals Inc.9$140
ACADIA Pharmaceuticals Inc5$121
Genentech USA, Inc.5$117
E.R. Squibb & Sons, L.L.C.3$78

Products named: CAPLYTA, REXULTI, ARISTADA, INGREZZA, AUSTEDO XR, VYEPTI, NUPLAZID, Ocrevus Zunovo.

Industry payments across TX — which companies pay providers there.